“…Several assays have been reported for the determination of oseltamivir and/or its active metabolite oseltamivir carboxylate in different biological matrices such as rat plasma [7] , [8] , [9] , [10] , mouse plasma [9] , rat urine [9] , rat cerebrospinal fluid [10] , rat brain [10] , rat dried blood spot (DBS) [11] , human DBS [11] , human saliva [12] , human urine [9] , [10] , [12] , [13] , human blood [13] , human tissue [13] , human serum [14] and human plasma [9] , [10] , [12] , [15] , [16] , [17] , [18] . Although there are many reports dealing with simultaneous estimation of OST and OSTC in biological samples [8] , [9] , [10] , [11] , [12] , [16] , [18] , relatively few methods have been used for bioequivalence/pharmacokinetic study in patients [18] or healthy volunteers [4] , [5] , [14] .…”